Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors

DARMSTADT, Germany, January 24, 2019 /PRNewswire/ -- Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical ... Lees verder

Bron:

ANP Pers support